Home/Filings/4/0001415889-24-019811
4//SEC Filing

Huang Michael F. 4

Accession 0001415889-24-019811

CIK 0001484565other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 9:03 AM ET

Size

5.5 KB

Accession

0001415889-24-019811

Insider Transaction Report

Form 4
Period: 2024-07-17
Huang Michael F.
Sr. VP of Clinical Development
Transactions
  • Award

    Common Stock

    2024-07-17+35,00035,000 total
Footnotes (2)
  • [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 50% of the RSUs subject to the award shall vest on the NDA Approval Date and 50% of the RSUs subject to the award shall vest on the one year anniversary of the NDA Approval Date, subject to the Reporting Person continuing as a service provider through each such date.
  • [F2]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Issuer

SOLENO THERAPEUTICS INC

CIK 0001484565

Entity typeother

Related Parties

1
  • filerCIK 0002019992

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 9:03 AM ET
Size
5.5 KB